March 20, 2016
Looking to strengthen its position in the Canadian pharmaceutical supply chain, McKesson has agreed to acquire Rexall Health from the Katz Group, a deal that’s expected to close late in 2016. The acquisition will provide McKesson Canada with Rexall Health’s Business.
This new addition is set to expand McKesson’s retail systems, and clinic footprint. Pangaea estimates the acquisition positions McKesson’s retail dollar market share at approximately 16%. The Canadian pharmaceutical market is experiencing rapid changes, prompting healthcare services companies to adapt. So expect more distributor channel M&A’s to come! For more information please contact Ana Padron, Trade Relations Manager, The Pangaea Group